Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Pemetrexed

Iliana Ramos Morales  1 , Matthew J. Yacobucci  2 , Conor Sheehy  3
In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Free Books & Documents
Book

Pemetrexed

Iliana Ramos Morales et al.
Free Books & Documents

Excerpt

The field of oncology continually evolves due to ongoing research and advancements in treatment modalities. Pemetrexed is a key chemotherapeutic agent used to treat various cancer types, including non-small cell lung cancer, mesothelioma, bladder cancer, breast cancer, and several other solid tumors. Understanding potential adverse effects, such as hematological toxicities, nephrotoxicity, and hypersensitivity reactions, is crucial for effective patient management and improved quality of life.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Iliana Ramos Morales declares no relevant financial relationships with ineligible companies.

Disclosure: Matthew Yacobucci declares no relevant financial relationships with ineligible companies.

Disclosure: Conor Sheehy declares no relevant financial relationships with ineligible companies.

References

    1. Vergote I, Calvert H, Kania M, Kaiser C, Zimmermann AH, Sehouli J. A randomised, double-blind, phase II study of two doses of pemetrexed in the treatment of platinum-resistant, epithelial ovarian or primary peritoneal cancer. Eur J Cancer. 2009 May;45(8):1415-23. - PubMed
    1. Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, Gatzemeier U, Boyer M, Emri S, Manegold C, Niyikiza C, Paoletti P. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol. 2003 Jul 15;21(14):2636-44. - PubMed
    1. Chattopadhyay S, Moran RG, Goldman ID. Pemetrexed: biochemical and cellular pharmacology, mechanisms, and clinical applications. Mol Cancer Ther. 2007 Feb;6(2):404-17. - PubMed
    1. Taylor EC, Kuhnt D, Shih C, Rinzel SM, Grindey GB, Barredo J, Jannatipour M, Moran RG. A dideazatetrahydrofolate analogue lacking a chiral center at C-6, N-[4-[2-(2-amino-3,4-dihydro-4-oxo-7H-pyrrolo[2,3-d]pyrimidin-5- yl)ethyl]benzoyl]-L-glutamic acid, is an inhibitor of thymidylate synthase. J Med Chem. 1992 Nov 13;35(23):4450-4. - PubMed
    1. Ceresoli GL, Zucali PA, Favaretto AG, Grossi F, Bidoli P, Del Conte G, Ceribelli A, Bearz A, Morenghi E, Cavina R, Marangolo M, Parra HJ, Santoro A. Phase II study of pemetrexed plus carboplatin in malignant pleural mesothelioma. J Clin Oncol. 2006 Mar 20;24(9):1443-8. - PubMed

Publication types

LinkOut - more resources